Market Tracker

07/29 6:01pm ET

Apricus Biosciences Inc (NASDAQ:APRI)

1.49
Delayed Data
As of Jul 29
 +0.02 / +1.36%
Today’s Change
0.92
Today|||52-Week Range
2.75
+49.00%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.47
Today’s open1.49
Day’s range1.48 - 1.55
Volume74,722
Average volume (3 months)122,329
Market cap$74.1M
Dividend yield--
Data as of 3:58pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)-20.30%
Earnings growth (this year)+9.09%
Earnings growth (next 5 years)--
Revenue growth (last year)+268.74%
P/E ratioNM
Price/Sales4.27
Price/Book33.96

Competitors

 Today’s
change
Today’s
% change
MSTXMast Therapeutics In...-0.01-1.26%
--United Gene High-Tec...-0.00-3.85%
OCRXOcera Therapeutics I...+0.08+2.09%
STDYSteadymed Ltd-0.03-0.54%
Data as of 3:59pm ET, 07/29/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.3M
Annual profit (last year)-$21.8M
Net profit margin-242.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, Secretary &
Director
Richard W. Pascoe
Chief Accounting Officer &
Vice President-Finance
Catherine Bovenizer
Corporate headquarters
San Diego, California

Forecasts